Get started
PPP

PYC THERAPEUTICS LIMITED

No trades
See on Supercharts
Overview
Financials Discussions Seasonals

PYCDA chart


Full chart

Key stats


Market capitalization
‪827.32 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.095 AUD
Net income (FY)
‪−37.73 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪127.52 M‬
Beta (1Y)
—

About PYC THERAPEUTICS LIMITED


Sector
Health Technology
CEO
Rohan Hockings
Headquarters
Nedlands
Website
pyctx.com
Founded
2001
ISIN
AU0000362352
FIGI
BBG000BWKBQ1
PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. It develops intracellular biological therapeutics including its own preclinical oncology payloads, using its proprietary cell Functional Penetrating Phylomers. The company was founded by Richmond Miles Hopkins and Paul Michael Watt on October 9, 2001, and is headquartered in Nedlands, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PYCDA is 1.790 AUD — it has decreased by −3.24% in the past 24 hours. Watch PYC THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PYC THERAPEUTICS LIMITED stocks are traded under the ticker PYCDA.
PYCDA stock has risen by 2.29% compared to the previous week, the month change is a 2.29% rise, over the last year PYC THERAPEUTICS LIMITED has showed a 2.29% increase.
PYCDA reached its all-time high on Nov 15, 2024 with the price of 1.955 AUD, and its all-time low was 1.700 AUD and was reached on Nov 15, 2024. View more price dynamics on PYCDA chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track PYC THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
PYCDA net income for the last half-year is ‪−22.63 M‬ AUD, while the previous report showed ‪−15.09 M‬ AUD of net income which accounts for −49.92% change. Track more PYC THERAPEUTICS LIMITED financial stats to get the full picture.
No, PYCDA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PYCDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PYC THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.